Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diabetic autonomic neuropathy.

Aaron I Vinik1, Roy Freeman, Tomris Erbas

  • 1Strelitz Diabetes Research Institutes, Eastern Virginia Medical School, Norfolk, Virginia 23510, USA.

Seminars in Neurology
|April 17, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Focus on renal morphology, chronic kidney disease, and urinary system malignancies in acromegaly: report on data collected over a 40-year period.

Pituitary·2026
Same author

Cancer risk in a large acromegaly cohort: a standardized incidence ratio analysis.

Pituitary·2026
Same author

Pure Autonomic Failure and Central Synucleinopathy Risk.

JAMA neurology·2026
Same author

The Syn-Q study: detection of cutaneous phosphorylated alpha-synuclein in Parkinson's disease progression: a trial protocol.

Frontiers in neurology·2026
Same author

Heterogeneity in endocrine monitoring and timing of endocrinology involvement during immune checkpoint inhibitor therapy: A Real-World Single-Center study.

Endocrine·2026
Same author

The Syn-sleep trial protocol: detection of cutaneous phosphorylated alpha-synuclein in REM sleep behavior disorder.

Biomarkers in medicine·2026

Diabetic autonomic neuropathy, a common diabetes complication, significantly impacts patient health and healthcare costs. Emerging research suggests nerve regeneration may offer a brighter future for affected individuals.

Area of Science:

  • Endocrinology
  • Neurology
  • Diabetology

Background:

  • Diabetic autonomic neuropathy (DAN) is a prevalent and debilitating complication of diabetes mellitus.
  • It affects multiple organ systems, leading to significant morbidity, mortality, and reduced quality of life.
  • DAN contributes substantially to increased healthcare costs associated with diabetes management.

Purpose of the Study:

  • To review the clinical manifestations and complications of diabetic autonomic neuropathy.
  • To explore the pathogenetic factors contributing to the development of DAN.
  • To discuss future therapeutic strategies targeting the underlying causes of DAN.

Main Methods:

  • Literature review of clinical manifestations and complications of DAN.
  • Analysis of pathogenetic factors including altered metabolism, vascular insufficiency, and autoimmune processes.

Related Experiment Videos

  • Discussion of ongoing research into nerve regeneration.

    • Main Results:

    • DAN presents with diverse clinical manifestations, often affecting single organ systems despite diffuse nervous system involvement.
    • Key pathogenetic factors include metabolic derangements, vascular compromise, impaired growth factor support, and autoimmune nerve damage.
    • Current research indicates potential for autonomic nerve regeneration.

    Conclusions:

    • Understanding the pathogenesis of DAN is crucial for developing targeted, cause-directed therapies.
    • Future therapeutic strategies may focus on promoting nerve regeneration, offering improved outcomes for patients.
    • The outlook for individuals with diabetic autonomic neuropathy is becoming more optimistic with ongoing research.